Similar Articles
Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis
Nuh ATAŞ, Özkan VARAN, Hakan BABAOĞLU, Hasan SATIŞ, Reyhan BİLİCİ SALMAN, Abdurrahman TUFAN
DOI: 10.5606/ArchRheumatol.2019.7177
Diagnostic Sensitivity of Different Applications of Pathergy Test for Behçet’s Disease
İncilay KALAY YILDIZHAN, Ayse BOYVAT
DOI: 10.5606/ArchRheumatol.2020.7380
Neurovascular Behçet's Disease Presenting with Cavernous Sinus Thrombosis: A Rare Case of Assumed Tolosa-Hunt-Like Syndrome
Chong Hyuk CHUNG, Myeung Su LEE, Changhoon LEE
DOI: 10.5606/ArchRheumatol.2020.7351
Pre-Pulseless Takayasu Arteritis in a Child Represented With Prolonged Fever of Unknown Origin and Successful Management With Concomitant Mycophenolate Mofetil and Infliximab
Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Ferhat Can PİŞKİN, Celal VARAN, Sevcan ERDEM, Mustafa YILMAZ
DOI: 10.46497/ArchRheumatol.2020.7599
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry
Marco SEBASTIANI, Andreina MANFREDI, Florenzo IANNONE, Elisa GREMESE, Alessandra BORTOLUZZI, Ennio FAVALLI, Chiara BAZZANI, Fausto SALAFFI, Enrico FUSARO, Rosario FOTI, Chiara GIANNITTI, Roberto CAPORALI, Alberto CAULI, Giulia CASSONE, Giuseppe LOPALCO, Luca PETRICCA, Gianfranco FERRACCIOLI, Giovanni LAPADULA
DOI: 10.46497/ArchRheumatol.2020.7499
Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy
Kenji YAMAZAKI, Etsuji SUZUKI, Ryuhei ISHIHARA, Toshiaki MIYAMOTO
DOI: 10.46497/ArchRheumatol.2020.7852
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.46497/ArchRheumatol.2021.7953
Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks
Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK
DOI: 10.46497/ArchRheumatol.2021.7806
The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients
Veli Yazısız, Vural Taner Yılmaz, İsmail Uçar, Özgür Dandin, Bengisu Aslan, Funda Erbasan, Hüseyin Koçak, Mustafa Ender Terzioğlu
DOI: 10.46497/ArchRheumatol.2021.8500
Evaluating various radiographic methods of shoulder joint damage in patients with rheumatoid arthritis receiving biological disease-modifying antirheumatic drugs
Kazuhito Sugimori, Isao Matsushita, Tomoatsu Kimura
DOI: 10.46497/ArchRheumatol.2021.8236
Association of TNFAIP3 gene polymorphism (rs5029939) with susceptibility and clinical phenotype of systemic lupus erythematosus
Hala Gaballah, Reham Abd-elkhalek, Ola Hussein, Shimaa Abd El-wahab
DOI: 10.46497/ArchRheumatol.2022.8769
Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients
Samer Mohammed, Munaf Zalzala, Faiq Gorial
DOI: 10.46497/ArchRheumatol.2022.9272
Can optical coherence tomography angiography be a first line ophthalmological evaluation in patients with Behçet’s disease?
Dilhan Karaca, Aynur Dıraçoğlu, Feyza Önder
DOI: 10.46497/ArchRheumatol.2023.9494
Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
Sadettin Uslu, Semih Gülle, Özkan Urak, Gerçek Şen, Ediz Dalkılıç, Soner Şenel, Servet Akar, Nevsun İnanç, Ayşe Cefle, Aydan Köken Avşar, Servet Yolbaş, Sema Yılmaz, Özgül Soysal Gündüz, İsmail Sarı, Merih Birlik, Nurullah Akkoç, Fatoş Önen
DOI: 10.46497/ArchRheumatol.2024.10391
Diastolic dysfunction in Behçet's disease and its relationship with clinical manifestations of the disease: A case-control study
Gizem Varkal, Rabia Eker Akıllı, İpek Türk, Zeynep Tüzün, Burak Mete, Süleyman Özbek
DOI: 10.46497/ArchRheumatol.2024.10772